Esperion Therapeutics, Inc.
ESPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$31 | -$13 | -$40 | -$21 |
| Dep. & Amort. | $1 | $0 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $3 | $2 | $3 |
| Change in WC | $10 | -$26 | $12 | -$21 |
| Other Non-Cash | $14 | $5 | $3 | $5 |
| Operating Cash Flow | -$4 | -$31 | -$23 | -$35 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $35 |
| Stock Issued | $0 | $3 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $11 | $0 | -$8 | $0 |
| Financing Cash Flow | $11 | $3 | -$8 | $35 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6 | -$29 | -$30 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $86 | $115 | $145 | $145 |
| End Cash | $92 | $86 | $115 | $145 |
| Free Cash Flow | -$4 | -$31 | -$23 | -$35 |